We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+17.03%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$16.4M
AUM Growth
-$217K
Cap. Flow
-$39.4M
Cap. Flow %
-239.84%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
3
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
BBNX
Beta Bionics
BBNX
+$4.9M
2
IMDX
Insight Molecular Diagnostics
IMDX
+$2.62M
3
CAI
Caris Life Sciences
CAI
+$1.43M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$38.5M
2
OM icon
Outset Medical
OM
+$6.61M
3
ESTA icon
Establishment Labs
ESTA
+$1.84M
4
MGX icon
Metagenomi Therapeutics
MGX
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBNX
1
Beta Bionics
BBNX
$715M
$5.59M 34.05%
281,250
+278,750
+11,150% +$4.9M
IMDX
2
Insight Molecular Diagnostics
IMDX
$156M
$3.14M 19.16%
947,134
+928,434
+4,965% +$2.62M
CAI
3
Caris Life Sciences
CAI
$6.43B
$2.72M 16.58%
89,940
+44,940
+100% +$1.43M
ESTA icon
4
Establishment Labs
ESTA
$2.28B
$1.84M 11.24%
45,000
-44,940
-50% -$1.84M
NSPR icon
5
InspireMD
NSPR
$34.7M
$1.09M 6.62%
450,517
– –
OM icon
6
Outset Medical
OM
$90.8M
$1M 6.09%
5,000
-424,120
-99% -$6.61M
MGX icon
7
Metagenomi Therapeutics
MGX
$46.3M
$627K 3.82%
264,391
-687,743
-72% -$1.4M
NTRA icon
8
Natera
NTRA
$46.1B
$402K 2.45%
2,500
-243,191
-99% -$38.5M

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM

Pura Vida Investments's Q3 2025 Portfolio in Review

As of Q3 2025, Pura Vida Investments held 8 positions worth $16.4M, down 1.3% from $16.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Pura Vida Investments withdrew a net $39.4M in Q3 2025, reducing 4 holdings. Its largest reduction was Natera, cutting an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Pura Vida Investments added an estimated $4.9M to Beta Bionics.

  • Pura Vida Investments added most to Beta Bionics in Q3 2025, an estimated $4.9M increase.
  • Pura Vida Investments's biggest Q3 2025 reduction was Natera, cutting an estimated $38.5M.
  • Pura Vida Investments's ten largest holdings make up 100% of its $16.4M portfolio in Q3 2025.
  • Pura Vida Investments opened 0 new positions and closed 0 in Q3 2025.
  • Pura Vida Investments's portfolio value fell 1.3% quarter-over-quarter to $16.4M.

Based on Pura Vida Investments's 13F filing for Q3 2025, filed 12 Nov 2025.